The Formulary Alignment: How Insurance Incentives for Generic Drugs Translate Into Real Savings for Policyholders
Insurance companies are often viewed with suspicion when they steer patients toward generic medications, but the financial mechanics behind that preference are more consumer-friendly than most policyholders realize. Understanding how pharmacy benefit managers negotiate drug costs—and how those negotiations flow back into premium and copay structures—reveals a rare case in which corporate and consumer interests genuinely converge.